Namita Thapar's Emcure Pharmaceuticals had a strong stock market debut, with shares listing 31.5% above the issue price. The successful IPO, valued at Rs 1,952.03 crores, reflects significant investor interest. Namita's career progression from a chartered accountant to Executive Director showcases her dedication and business acumen.
